Concepedia

First-dose effects of fingolimod: Pooled safety data from three phase 3 studies

John Dimarco, Paul O’Connor, Jeffrey A. Cohen, Anthony T. Reder, Lixin Zhang-Auberson, Dejun Tang, William Collins, Ludwig Kappos

Multiple Sclerosis and Related Disorders · 2014 · 85 citations · 13 references

DOI

Concepts

References

13

WORLD MEDICAL ASSOCIATION DECLARATION OF HELSINKI: Ethical Principles for Medical Research Involving Human Subjects

Journal of obstetrics and gynaecology research · 2001 · 3.5K citations · Full text

, , +13

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

Ludwig Kappos, Ernst‐Wilhelm Radue, Paul O’Connor et al. · New England Journal of Medicine · 2010 · 2.6K citations · Full text

, , +14

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis

Jeffrey A. Cohen, Frederik Barkhof, Hans‐Peter Hartung et al. · New England Journal of Medicine · 2010 · 2.2K citations · Full text

, , +15

Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis

Ludwig Kappos, Jack P. Antel, Giancarlo Comi et al. · New England Journal of Medicine · 2006 · 1.1K citations · Full text

, , +8

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

Peter A. Calabresi, Ernst-Wilhelm Radüe, Douglas S. Goodin et al. · The Lancet Neurology · 2014 · 822 citations

, , +7